These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 33501498)

  • 1. Histopathologic Features of Chilblainlike Lesions Developing in the Setting of the Coronavirus Disease 2019 (COVID-19) Pandemic.
    Sohier P; Matar S; Meritet JF; Laurent-Roussel S; Dupin N; Aractingi S
    Arch Pathol Lab Med; 2021 Feb; 145(2):137-144. PubMed ID: 33501498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chilblain-like acral lesions during the COVID-19 pandemic ("COVID toes"): Histologic, immunofluorescence, and immunohistochemical study of 17 cases.
    Kanitakis J; Lesort C; Danset M; Jullien D
    J Am Acad Dermatol; 2020 Sep; 83(3):870-875. PubMed ID: 32502585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinicopathological description of COVID-19-induced chilblains (COVID-toes) correlated with a published literature review.
    Kolivras A; Thompson C; Pastushenko I; Mathieu M; Bruderer P; de Vicq M; Feoli F; Harag S; Meiers I; Olemans C; Sass U; Dehavay F; Fakih A; Lam-Hoai XL; Marneffe A; Van De Borne L; Vandersleyen V; Richert B
    J Cutan Pathol; 2022 Jan; 49(1):17-28. PubMed ID: 34272741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review of COVID-19 Chilblains-like Lesions and their Differential Diagnosis.
    Adv Skin Wound Care; 2021 Jul; 34(7):1. PubMed ID: 34125733
    [No Abstract]   [Full Text] [Related]  

  • 5. Going viral: A brief history of Chilblain-like skin lesions ("COVID toes") amidst the COVID-19 pandemic.
    Massey PR; Jones KM
    Semin Oncol; 2020 Oct; 47(5):330-334. PubMed ID: 32736881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Chilblains as a Manifestation of the COVID-19 Pandemic.
    Herman A; Peeters C; Verroken A; Tromme I; Tennstedt D; Marot L; Dachelet C; Gruson D; Hermans C; Baeck M
    JAMA Dermatol; 2020 Sep; 156(9):998-1003. PubMed ID: 32584377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cutaneous lesions in COVID-19 patients].
    Çiftçi Z; Clabbers JMK; Galimont-Collen AFS; Gostyński A
    Ned Tijdschr Geneeskd; 2020 Dec; 164():. PubMed ID: 33332042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases.
    Colmenero I; Santonja C; Alonso-Riaño M; Noguera-Morel L; Hernández-Martín A; Andina D; Wiesner T; Rodríguez-Peralto JL; Requena L; Torrelo A
    Br J Dermatol; 2020 Oct; 183(4):729-737. PubMed ID: 32562567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic perniosis presenting as acral purpuric lesions: Clustering of cases before COVID-19 pandemic and their comparison with chilblain like lesions reported in the literature.
    Jindal R; Chauhan P; Goyal D; Shirazi N
    Dermatol Ther; 2021 May; 34(3):e14951. PubMed ID: 33740317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID 19-associated chilblain-like acral lesions among children and adolescents: an Italian retrospective, multicenter study.
    Romita P; Maronese CA; DE Marco A; Balestri R; Belloni Fortina A; Brazzelli V; Colonna C; DI Lernia V; El Hachem M; Fabbrocini G; Foti C; Frasin LA; Guarneri C; Guerriero C; Guida S; Locatelli A; Neri I; Occella C; Offidani A; Oranges T; Pellacani G; Stinco G; Stingeni L; Barbagallo T; Campanati A; Cannavò SP; Caroppo F; Cavalli R; Costantini A; Cucchia R; Diociaiuti A; Filippeschi C; Francomano M; Giancristoforo S; Giuffrida R; Martina E; Monzani NA; Nappa P; Pastorino C; Patrizi A; Peccerillo F; Peris K; Recalcati S; Rizzoli L; Simonetti O; Vastarella M; Virdi A; Marzano AV; Bonamonte D
    Ital J Dermatol Venerol; 2023 Apr; 158(2):117-123. PubMed ID: 37153946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronavirus (COVID-19) Infection-Induced Chilblains: A Brisk Perieccrine Inflammatory Response.
    Wargo JJ; Weir NM; Shamma HN
    Am J Dermatopathol; 2021 Feb; 43(2):144-145. PubMed ID: 32618705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic.
    Hubiche T; Cardot-Leccia N; Le Duff F; Seitz-Polski B; Giordana P; Chiaverini C; Giordanengo V; Gonfrier G; Raimondi V; Bausset O; Adjtoutah Z; Garnier M; Burel-Vandenbos F; Dadone-Montaudié B; Fassbender V; Palladini A; Courjon J; Mondain V; Contenti J; Dellamonica J; Leftheriotis G; Passeron T
    JAMA Dermatol; 2021 Feb; 157(2):202-206. PubMed ID: 33237291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of a Child vs an Adult Presenting With Acral Lesions During the COVID-19 Pandemic: A Practical Review.
    Clawson RC; Tabata MM; Ko JM
    Cutis; 2021 Mar; 107(3):139-142. PubMed ID: 33956605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of Clinicopathologic Findings in COVID-19-induced Skin Lesions: Demonstration of Direct Viral Infection of the Endothelial Cells.
    Garrido Ruiz MC; Santos-Briz Á; Santos-Briz Á; Sánchez A; Alonso-Riaño M; Burgos J; Medina-Miguelañez M; Puebla L; Román-Curto C; Roncero-Riesco M; Garcia R; Ortiz PL; Rodriguez-Peralto JL
    Am J Surg Pathol; 2021 Mar; 45(3):293-303. PubMed ID: 33399338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection.
    El Hachem M; Diociaiuti A; Concato C; Carsetti R; Carnevale C; Ciofi Degli Atti M; Giovannelli L; Latella E; Porzio O; Rossi S; Stracuzzi A; Zaffina S; Onetti Muda A; Zambruno G; Alaggio R
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2620-2629. PubMed ID: 32474947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approach to Chilblains During the COVID-19 Pandemic [Formula: see text].
    Ladha MA; Luca N; Constantinescu C; Naert K; Ramien ML
    J Cutan Med Surg; 2020; 24(5):504-517. PubMed ID: 32741218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major cluster of paediatric 'true' primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown.
    Neri I; Virdi A; Corsini I; Guglielmo A; Lazzarotto T; Gabrielli L; Misciali C; Patrizi A; Lanari M
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2630-2635. PubMed ID: 32533899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral Chilblain-like Lesions of the Toes Characterized by Microvascular Remodeling in Adolescents During the COVID-19 Pandemic.
    Discepolo V; Catzola A; Pierri L; Mascolo M; Della Casa F; Vastarella M; Smith G; Travaglino A; Punziano A; Nappa P; Staibano S; Bruzzese E; Fabbrocini G; Guarino A; Alessio M
    JAMA Netw Open; 2021 Jun; 4(6):e2111369. PubMed ID: 34110396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous Manifestations of COVID-19 in the Inpatient Setting.
    Do MH; Stewart CR; Harp J
    Dermatol Clin; 2021 Oct; 39(4):521-532. PubMed ID: 34556242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No SARS-CoV-2 antibody response in 25 patients with pseudo-chilblains.
    Docampo-Simón A; Sánchez-Pujol MJ; Gimeno-Gascon A; Palazón-Cabanes JC; Juan-Carpena G; Vergara-De Caso E; González-Villanueva I; Blanes-Martínez M; Betlloch-Mas I
    Dermatol Ther; 2020 Nov; 33(6):e14332. PubMed ID: 32975345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.